A carcinoembryonic antigen-specific cell therapy selectively targets tumor cells with HLA loss of heterozygosity in vitro and in vivo.

MLA

Sandberg, Mark L., et al. “A Carcinoembryonic Antigen-Specific Cell Therapy Selectively Targets Tumor Cells with HLA Loss of Heterozygosity in Vitro and in Vivo.” Science Translational Medicine, vol. 14, no. 634, Mar. 2022, p. eabm0306. EBSCOhost, https://doi.org/10.1126/scitranslmed.abm0306.

APA

Sandberg, M. L., Wang, X., Martin, A. D., Nampe, D. P., Gabrelow, G. B., Li, C. Z., McElvain, M. E., Lee, W.-H., Shafaattalab, S., Martire, S., Fisher, F. A., Ando, Y., Liu, E., Ju, D., Wong, L. M., Xu, H., & Kamb, A. (2022). A carcinoembryonic antigen-specific cell therapy selectively targets tumor cells with HLA loss of heterozygosity in vitro and in vivo. Science Translational Medicine, 14(634), eabm0306. https://doi.org/10.1126/scitranslmed.abm0306

Chicago

Sandberg, Mark L, Xueyin Wang, Aaron D Martin, Daniel P Nampe, Grant B Gabrelow, Chuck Z Li, Michele E McElvain, et al. 2022. “A Carcinoembryonic Antigen-Specific Cell Therapy Selectively Targets Tumor Cells with HLA Loss of Heterozygosity in Vitro and in Vivo.” Science Translational Medicine 14 (634): eabm0306. doi:10.1126/scitranslmed.abm0306.